Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid (RGD) in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement

Recruiting now · Not applicable

Conditions studied: Implant Dentistry

In brief

The aim of the present study is to evaluate the efficacy of xenograft alone or xenograft mixed with Arginylglycylaspartic acid (RGD) , in horizontal ridge augmentation with split-crest technique, for implant placement.

Key facts

Study ID

NCT06585852

Run by

Al-Azhar University

People needed

18

Starts

2023-08-01

Expected to finish

2024-10-15

Last updated by the study team

2024-09-19

Who can join

Age: 18 and older, up to 30. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults (age 18-30) exhibiting initial insufficiently bone width.
• Patients with good oral hygiene.
• Patients must be free from systemic diseases that may influence the outcome of the therapy.
• Patients with bony horizontal defects alone, Class III \& IV.

You may not qualify if…

• Heavy smokers.
• Patient treated by immunosuppressive chemotherapy or radio therapy,
• Allergy to any material or medication used in the study.
• Pregnant females.

Where it is running

• Al Azhar University of Cairo — Cairo, Nasr City, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.